Document is current

Article History

Received: 9 August 2024

Accepted: 8 December 2024

First Online: 7 January 2025

Declarations

:

: The BHR was established by the University of California, San Francisco (UCSF) and is reviewed and approved by UCSF’s institutional review board. All participants provided online informed consent, and the research was conducted in accordance with the Declaration of Helsinki.

: Not applicable.

: Manchumad Manjavong, Chengshi Jin, Adam Diaz, Miriam T. Ashford, Joseph Eichenbaum, Emily Thorp, Elizabeth Wragg, Kenton H. Zavitz, Francesca Cormack, Anna Aaronson, R. Scott Mackin, Rachana Tank, Bernard Landavazo, Erika Cavallone, Diana Truran, and Sarah Tomaszewski Farias have nothing to disclose. Jae Myeong Kang reports grants from Gachon University, during the conduct of the study. Rachel L. Nosheny reports grants from NIA, during the conduct of the study. Michael W. Weiner serves on Editorial Boards for Alzheimer’s & Dementia, and the Journal for Prevention of Alzheimer’s Disease (JPAD); He has served on Advisory Boards for Acumen Pharmaceutical, Alzheon, Inc., Amsterdam UMC; MIRIADE, Cerecin, Merck Sharp & Dohme Corp., NC Registry for Brain Health, and REGEnLIFE. He also serves on the USC ACTC grant which receives funding from Eisai; He has provided consulting to Boxer Capital, LLC, Cerecin, Inc., Clario, Dementia Society of Japan, Dolby Family Ventures, Eisai, Guidepoint, Health and Wellness Partners, Indiana University, LCN Consulting, MEDA Corp., Merck Sharp & Dohme Corp., NC Registry for Brain Health, Prova Education, T3D Therapeutics, University of Southern California (USC), and WebMD; He has acted as a speaker/lecturer for China Association for Alzheimer’s Disease (CAAD) and Taipei Medical University, as well as a speaker/lecturer with academic travel funding provided by: AD/PD Congress, Amsterdam UMC, Cleveland Clinic, CTAD Congress, Foundation of Learning; Health Society (Japan), Kenes, U. Penn, U. Toulouse, Japan Society for Dementia Research, Korean Dementia Society, Merck Sharp & Dohme Corp., National Center for Geriatrics and Gerontology (NCGG; Japan), University of Southern California (USC); He holds stock options with Alzeca, Alzheon, Inc., ALZPath, Inc., and Anven; He received support for his research from the following funding sources: National Institutes of Health (NIH)/NINDS/National Institute on Aging (NIA), Department of Defense (DOD), California Department of Public Health (CDPH), University of Michigan, Siemens, Biogen, Hillblom Foundation, Alzheimer’s Association, Johnson & Johnson, Kevin and Connie Shanahan, GE, VUmc, Australian Catholic University (HBI-BHR), The Stroke Foundation, and the Veterans Administration.